Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Serina Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 25 | 23 | −2 |
| Shares | 335.8K | 413.1K | +77.4K (+23.0%) |
| Value | $1.90M | $2.54M | +$641.1K (+33.7%) |
New holders (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 13,237 | $81.5K | 0.00% |
| Raymond James Financial Inc | 38 | $234 | 0.00% |
| Global Retirement Partners, LLC | 1 | $6 | 0.00% |
Sold out (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 13,184 | $74.8K |
| Millennium Management LLC | 10,721 | $60.8K |
| Tower Research Capital LLC (TRC) | 912 | $5.17K |
| Ameriflex Group, Inc. | 2 | $11 |
| FMR LLC | 1 | $8 |